Enhabit, Inc. (NYSE:EHAB) Receives $9.35 Consensus Target Price from Analysts

Enhabit, Inc. (NYSE:EHAB - Get Free Report) has earned a consensus rating of "Reduce" from the seven research firms that are presently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating and six have issued a hold rating on the company. The average 1 year price objective among brokers that have issued a report on the stock in the last year is $9.25.

Separately, Leerink Partners reiterated a "market perform" rating and set a $8.00 target price (down previously from $8.50) on shares of Enhabit in a research report on Tuesday.

Insider Buying and Selling

In related news, Director Jeffrey Bolton bought 5,000 shares of the business's stock in a transaction that occurred on Thursday, August 22nd. The stock was bought at an average cost of $8.01 per share, for a total transaction of $40,050.00. Following the completion of the transaction, the director now owns 78,877 shares of the company's stock, valued at approximately $631,804.77. The trade was a 6.77 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.90% of the stock is currently owned by insiders.

Institutional Trading of Enhabit

Hedge funds and other institutional investors have recently bought and sold shares of the company. FMR LLC boosted its position in Enhabit by 138.4% during the third quarter. FMR LLC now owns 3,388 shares of the company's stock valued at $27,000 after buying an additional 1,967 shares during the period. Gladius Capital Management LP purchased a new stake in Enhabit during the 2nd quarter valued at about $31,000. Quarry LP grew its position in Enhabit by 242.2% during the 2nd quarter. Quarry LP now owns 3,703 shares of the company's stock worth $33,000 after acquiring an additional 2,621 shares during the last quarter. Allspring Global Investments Holdings LLC purchased a new position in Enhabit in the 1st quarter worth approximately $44,000. Finally, ProShare Advisors LLC bought a new stake in Enhabit in the first quarter valued at approximately $118,000.

Enhabit Stock Performance

Shares of EHAB traded up $0.12 on Tuesday, reaching $7.27. 357,923 shares of the company's stock traded hands, compared to its average volume of 581,143. The stock's 50 day simple moving average is $7.54 and its two-hundred day simple moving average is $8.43. The company has a current ratio of 1.46, a quick ratio of 1.46 and a debt-to-equity ratio of 0.85. Enhabit has a 52-week low of $6.85 and a 52-week high of $11.74. The stock has a market cap of $365.31 million, a PE ratio of -3.13 and a beta of 1.84.

Enhabit (NYSE:EHAB - Get Free Report) last released its earnings results on Wednesday, November 6th. The company reported $0.03 EPS for the quarter, missing analysts' consensus estimates of $0.04 by ($0.01). The business had revenue of $253.60 million for the quarter, compared to the consensus estimate of $261.69 million. Enhabit had a positive return on equity of 1.67% and a negative net margin of 11.24%. During the same quarter in the previous year, the firm earned $0.03 earnings per share. On average, analysts forecast that Enhabit will post 0.25 earnings per share for the current fiscal year.

About Enhabit

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.